青少年特发性脊柱侧凸患者后路脊柱融合术后前2周伤口疼痛轨迹
前瞻性队列研究纳入2015年9月至12月计划行后路脊柱融合术的青少年特发性脊柱侧凸患者40例,采用患者自控镇痛吗啡、对乙酰氨基酚、塞来昔布和盐酸羟考酮胶囊的疼痛管理方案,评估术后第1天至第14天伤口疼痛轨迹。视觉模拟评分在术后12小时最高(6.0±2.3),术后第4天降至3.9±2.2,第7天降至1.9±1.6,第14天降至0.7±1.1。作者结论认为充分术后疼痛方案下显著疼痛应在术后第4天降至可耐受水平,第7天基本可忽略。
要点
- 术后12小时视觉模拟评分最高(6.0±2.3),第4天降至3.9±2.2,第7天降至1.9±1.6,第14天降至0.7±1.1。
- 患者自控镇痛吗啡总用量从术后前12小时12.4±9.9 mg降至36至48小时2.1±6.1 mg。
- 盐酸羟考酮胶囊用量在术后第4天达峰值1.4±2.8 mg,至第13天减至零。
核心结论
- 在充分术后疼痛方案下,显著疼痛应在术后第4天降至可耐受水平,术后第7天基本可忽略。
- 患者通常可在术后第4天出院,此时已不需要患者自控镇痛吗啡。
研究设计与样本
- 前瞻性队列研究,纳入2015年9月至12月计划行择期后路脊柱融合术的青少年特发性脊柱侧凸患者40例(36例女性,4例男性)。
- 所有患者接受相似的疼痛管理方案:患者自控镇痛吗啡、对乙酰氨基酚、塞来昔布和盐酸羟考酮胶囊。
主要发现
- 视觉模拟评分在术后12小时最高(6.0±2.3),术后第4天降至3.9±2.2,第7天降至1.9±1.6,第14天降至0.7±1.1。
- 所有患者患者自控镇痛吗啡总用量:术后前12小时12.4±9.9 mg,12至24小时7.1±8.0 mg,24至36小时5.6±6.9 mg,36至48小时2.1±6.1 mg。
- 塞来昔布胶囊用量从24小时215.0±152.8 mg降至第14天55.0±90.4 mg。
- 对乙酰氨基酚用量从24小时2275±1198 mg降至第14天150±483 mg。
- 盐酸羟考酮胶囊用量在术后第4天升至峰值1.4±2.8 mg,之后逐渐减少,至第13天减至零。
临床怎么用
- 作者结论认为,在充分术后疼痛方案下,显著疼痛应在术后第4天降至可耐受水平,术后第7天基本可忽略。
- 作者结论认为,患者通常可在术后第4天出院,此时已不需要患者自控镇痛吗啡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: A prospective cohort study. OBJECTIVE: The aim of this study was to determine and evaluate the trajectory of surgical wound pain from day 1 to day 14 after posterior spinal fusion (PSF) surgery in patients with adolescent idiopathic scoliosis (AIS). SUMMARY OF BACKGROUND DATA: Information regarding how the postoperative pain improves with time offers invaluable information not only to the patients and parents but also to assist the clinician in managing postoperative pain. METHODS: AIS patients who were planned for elective PSF surgery from September 2015 to December 2015 were prospectively recruited into this study. All patients underwent a similar pain management regimen with patient-controlled anesthesia (PCA) morphine, acetaminophen, celecoxib, and oxycodone hydrochloride. RESULTS: A total of 40 patients (36 F:4 M) were recruited. The visual analogue score (VAS) pain score was highest at 12 hours postoperation (6.0 ± 2.3). It reduced to 3.9 ± 2.2 (day 4), 1.9 ± 1.6 (day 7), and 0.7 ± 1.1 (day 14). The total PCA usage in all patients was 12.4 ± 9.9 mg (first 12 hours), 7.1 ± 8.0 mg (12 to 24 hours), 5.6 ± 6.9 (24-36 hours), and 2.1 ± 6.1 mg (36-48 hours). The celecoxib capsules usage was reducing from 215.0 ± 152.8 mg at 24 hours to 55.0 ± 90.4 mg on day 14. The acetaminophen usage was reducing from 2275 ± 1198 mg at 24 hours to 150 ± 483 mg at day 14. Oxycodone hydrochloride capsules consumption rose to the peak of 1.4 ± 2.8 mg on day 4 before gradually reducing to none by day 13. CONCLUSION: With an adequate postoperation pain regimen, significant pain should subside to a tolerable level by postoperative day 4 and negligible by postoperative day 7. Patient usually can be discharged on postoperative day 4 when the usage of PCA morphine was not required. LEVEL OF EVIDENCE: 2.
引用
- Kwan MK, Chiu CK, Chan TS, et al. Trajectory of Postoperative Wound Pain Within the First 2 Weeks Following Posterior Spinal Fusion Surgery in Adolescent Idiopathic Scoliosis Patients. Spine (Phila Pa 1976). 2017. PMID: 28538525. doi:10.1097/BRS.0000000000001902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。